165 related articles for article (PubMed ID: 6167518)
1. Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Mullers WJ; van Boven CP
Infect Immun; 1981 Jul; 33(1):178-85. PubMed ID: 6167518
[TBL] [Abstract][Full Text] [Related]
2. Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study.
Gonggrijp R; Mullers WJ; van Boven CP
Antonie Van Leeuwenhoek; 1983 Jun; 49(2):173-82. PubMed ID: 6193755
[TBL] [Abstract][Full Text] [Related]
3. Protection of chickens by ribosomal vaccines from Pasteurella multocida: dependence on homologous lipopolysaccharide.
Phillips M; Rimler RB
Am J Vet Res; 1984 Sep; 45(9):1785-9. PubMed ID: 6208828
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the presence of lipopolysaccharide in a ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Volleberg MP; Lemmens PJ; van Boven CP
Infect Immun; 1981 Mar; 31(3):896-905. PubMed ID: 6785242
[TBL] [Abstract][Full Text] [Related]
5. Ribonuclease-sensitive ribosomal vaccines.
Gonggrijp R; Antonissen AC; van den Bosch JF; van Boven CP
Antonie Van Leeuwenhoek; 1984; 50(5-6):763-74. PubMed ID: 6084981
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES; Lam JS
FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
[TBL] [Abstract][Full Text] [Related]
7. Ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Mullers WJ; Lemmens PJ; van Boven CP
Infect Immun; 1980 Jan; 27(1):204-10. PubMed ID: 6153637
[TBL] [Abstract][Full Text] [Related]
8. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa infection and vaccination in the rat.
Kostiala AA
J Med Microbiol; 1980 May; 13(2):201-12. PubMed ID: 6770090
[TBL] [Abstract][Full Text] [Related]
10. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
Lieberman MM; McKissock DC; Wright GL
Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
[TBL] [Abstract][Full Text] [Related]
11. Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV.
MacIntyre S; Lucken R; Owen P
Infect Immun; 1986 Apr; 52(1):76-84. PubMed ID: 3082762
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
13. Specific and nonspecific protection of mice by Pseudomonas aeruginosa lipopolysaccharides.
Marx A; Meitert E; Salageanu A; Olinescu A; Savulian C; Sima F; Chersulick E
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):154-62. PubMed ID: 3115002
[TBL] [Abstract][Full Text] [Related]
14. Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains.
Lieberman MM; Wright GL; Wolcott KM; McKissock-Desoto DC
Infect Immun; 1980 Aug; 29(2):489-93. PubMed ID: 6783532
[TBL] [Abstract][Full Text] [Related]
15. [Production and experimental testing of the polyvalency of corpuscular vaccine for the prevention of Pseudomonas aeruginosa infections II. Experimental testing of the immunogenicity of polyvalent corpuscular Pseudomonas aeruginosa vaccine].
Moroz AF; Antsiferova NG; Radkevich SA; Mishina VS
Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):74-80. PubMed ID: 6800165
[TBL] [Abstract][Full Text] [Related]
16. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
Matthews-Greer JM; Gilleland HE
J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa ribosomal vaccine. A comparison of the immunogenicity of vaccines from two different serotypes.
Lieberman MM
Antibiot Chemother (1971); 1989; 42():193-202. PubMed ID: 2512837
[No Abstract] [Full Text] [Related]
18. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity.
Lieberman MM
Infect Immun; 1978 Jul; 21(1):76-86. PubMed ID: 101464
[TBL] [Abstract][Full Text] [Related]
20. Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.
Kamei A; Coutinho-Sledge YS; Goldberg JB; Priebe GP; Pier GB
Infect Immun; 2011 Mar; 79(3):1289-99. PubMed ID: 21149583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]